Closed Meridian OS Workspace
The private engagement room included with every Meridian mandate.
Live workspaces are issued only after engagement approval. The interactive preview below shows how a principal or CIO reviews the mandate, opportunity pipeline, fit memos, source confidence, and the next decision — without inbox clutter.
See how a new office is set up — mandate, preferences, and team — in under two minutes.
Live Workspace Preview
Inside Meridian OS — the engagement room where the mandate lives.
A fully interactive demo on illustrative data for a fictional office. Move between the screens, filter the pipeline, open any opportunity, and act on it the way a principal would during a review cycle.
Bartlett Hale Family Office
Meridian OS · Engagement Room
Active review cycle
Overview
Executive status for the current review cycle — what moved, what is ready, and the next decision.
Allocation lens
See how the live pipeline maps to a target equity check.
$25M$50M$75M
Estimated pipeline value by sub-sector
Non-advisoryPipeline by stage
Ready for your review
What changed this week
Atlas Diagnostics cleared ownership checks and moved to ready-for-review.
Concord Dental returned to screening pending a sponsor pricing reset.
Northbridge memo upgraded after the founder succession path was validated.
3 new ophthalmology signals added to the universe from advisor channels.
Next review call
Thu, 18 Jun · 16:00 GMT
Principal + CIO. Agenda: Northbridge and Atlas advance decisions, dental watchlist, Q3 corridor weighting.
Coverage by corridor
Corridor counts reflect actively mapped companies, not endorsed opportunities. Estimated values are non-advisory and based on public or inferred ranges.
Review Board
The decision surface. Each opportunity carries a fit score and the reason it matters — open it, or act on it directly.
Mandate
The working definition of what the office is buying. Meridian screens against this; you refine it any time.
Mandate completeness
92%
Sectors
ClinicsDiagnosticsSpecialty careDentalHome careBehavioralAI-enabled services
Geographies
North AmericaEuropeUnited KingdomSingaporeGulf
Ticket size$25M – $150M equity
Revenue range$20M – $120M
Ownership preferenceControl or structured minority
Review cadenceWeekly cycle · biweekly call
Priority themes
Founder successionPlatform buildFragmented marketsRecurring revenueCash-pay resilienceAI-enabled efficiency
Exclusions
Early-stage / pre-revenueSingle-asset turnaroundsPure real estateHeavy government-reimbursement risk
Decision makersPrincipal + CIO
Capital postureDirect + selective co-invest
Opportunity Pipeline
Every mapped opportunity and its current stage. Filter by stage or sub-sector, sort by fit or value, and open any row.
AllReadyScreeningWatchlistFits ticketDisclosed
| Opportunity | Sub-sector | Geography | EV est. | Equity check | Stage | Fit | Updated |
|---|
No opportunities match these filters.
Stages: Sourced · Screening · Memo in progress · Ready for review · Client reviewing · Watchlist · Disclosed. EV estimates are non-advisory, based on public or inferred ranges. Disclosed items are routed separately from the neutral research set.
Intelligence
The smart layer over your pipeline — AI-assisted, human-verified recommendations, what the desk has learned about your mandate, and live market signals.
Recommended for your mandate
Human-verifiedAI-assisted matching, surfaced only after Meridian source-trail and ownership checks. Explanatory, not autonomous investment advice.
What the desk has learned
The mandate model sharpens as you act on opportunities. Current sub-sector weighting, inferred from your decisions and interest signals:
Pattern detected
Your interest skews toward founder-succession and cash-pay-resilient sub-sectors; the desk is up-weighting those signals and the AI-enabled healthcare lane.
Live market signals
- Multiples
Healthcare-services M&A reset to ~11.5x EV/EBITDA (2025) from ~14.5x (2024) — entry discipline favoured.
- AI adoption
~66% of physicians now use clinical AI, up from 38% in 2023 — the AI-enabled lane is strengthening.
- Dental
~130 PE-backed DSO platforms active; platform pricing resetting toward 8–12x EBITDA.
- Ophthalmology
Still only ~8% PE-penetrated — a long consolidation runway in a premium specialty.
Governance & access
Tenant-isolatedEncrypted & isolated
Every record carries your workspace ID. No cross-client leakage.
Role-based access
Principal, CIO, researcher, and external-advisor viewer permissions.
Full audit trail
Who created, edited, and reviewed every opportunity and document.
Conflict disclosure
Affiliated opportunities are routed to a separate disclosed lane.
Opportunity Detail
The full review page for a single opportunity — why it fits, what is unproven, and where every fact came from.
Documents & Fit Memos
Every output lives in the workspace, not across inboxes — memos, sector maps, source trails, and review decks.
Affiliated / Disclosed
EdgeNode Health Data Analytics
Meridian (or an affiliate) holds a vested interest in this company. It is kept in a separate disclosed lane and never mixed into the neutral research set. You decide how it is handled.
Conflict statusDisclosed · approved for client view
Nature of interestMeridian network / affiliate equity
Demo workspace using a fictional family-office identity and illustrative mandate data. Company names are composites; figures are illustrative ranges grounded in real sector multiples. Meridian operates the research desk — research, screening, and curation only, not brokerage or investment advice. Estimated pipeline value is non-advisory.